Mishra Dhatu Nigam Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 5, 2025, 4:38 pm

Competitors of Mishra Dhatu Nigam Ltd

All Competitor Stocks of Mishra Dhatu Nigam Ltd

Quarterly Result

Last Updated: August 20, 2025, 6:55 am

Below is a detailed analysis of the quarterly data for Mishra Dhatu Nigam Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 170.00 Cr.. The value appears to be declining and may need further review. It has decreased from 411.00 Cr. (Mar 2025) to 170.00 Cr., marking a decrease of 241.00 Cr..
• For Expenses, as of Jun 2025, the value is 136.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 317.00 Cr. (Mar 2025) to 136.00 Cr., marking a decrease of 181.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 34.00 Cr.. The value appears to be declining and may need further review. It has decreased from 93.00 Cr. (Mar 2025) to 34.00 Cr., marking a decrease of 59.00 Cr..
• For OPM %, as of Jun 2025, the value is 20.00%. The value appears to be declining and may need further review. It has decreased from 23.00% (Mar 2025) to 20.00%, marking a decrease of 3.00%.
• For Other Income, as of Jun 2025, the value is 7.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8.00 Cr. (Mar 2025) to 7.00 Cr., marking a decrease of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 6.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 7.00 Cr. (Mar 2025) to 6.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 16.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 19.00 Cr.. The value appears to be declining and may need further review. It has decreased from 77.00 Cr. (Mar 2025) to 19.00 Cr., marking a decrease of 58.00 Cr..
• For Tax %, as of Jun 2025, the value is 33.00%. The value appears to be increasing, which may not be favorable. It has increased from 27.00% (Mar 2025) to 33.00%, marking an increase of 6.00%.
• For Net Profit, as of Jun 2025, the value is 13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 56.00 Cr. (Mar 2025) to 13.00 Cr., marking a decrease of 43.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.68. The value appears to be declining and may need further review. It has decreased from 3.00 (Mar 2025) to 0.68, marking a decrease of 2.32.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:50 am

Balance Sheet

Last Updated: June 16, 2025, 11:42 am

Below is a detailed analysis of the balance sheet data for Mishra Dhatu Nigam Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 187.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 187.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,227.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,132.00 Cr. (Mar 2024) to 1,227.00 Cr., marking an increase of 95.00 Cr..
• For Borrowings, as of Mar 2025, the value is 350.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 433.00 Cr. (Mar 2024) to 350.00 Cr., marking a decrease of 83.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,150.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,154.00 Cr. (Mar 2024) to 1,150.00 Cr., marking a decrease of 4.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,914.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,906.00 Cr. (Mar 2024) to 2,914.00 Cr., marking an increase of 8.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,074.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,032.00 Cr. (Mar 2024) to 1,074.00 Cr., marking an increase of 42.00 Cr..
• For CWIP, as of Mar 2025, the value is 25.00 Cr.. The value appears to be declining and may need further review. It has decreased from 83.00 Cr. (Mar 2024) to 25.00 Cr., marking a decrease of 58.00 Cr..
• For Investments, as of Mar 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2024) to 25.00 Cr., marking an increase of 3.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,790.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,769.00 Cr. (Mar 2024) to 1,790.00 Cr., marking an increase of 21.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,914.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,906.00 Cr. (Mar 2024) to 2,914.00 Cr., marking an increase of 8.00 Cr..

Notably, the Reserves (1,227.00 Cr.) exceed the Borrowings (350.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Mishra Dhatu Nigam Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 5.92. This value is within the healthy range. It has increased from 4.90 (Mar 24) to 5.92, marking an increase of 1.02.
• For Diluted EPS (Rs.), as of Mar 25, the value is 5.92. This value is within the healthy range. It has increased from 4.90 (Mar 24) to 5.92, marking an increase of 1.02.
• For Cash EPS (Rs.), as of Mar 25, the value is 9.26. This value is within the healthy range. It has increased from 8.00 (Mar 24) to 9.26, marking an increase of 1.26.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 75.53. It has increased from 70.42 (Mar 24) to 75.53, marking an increase of 5.11.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 75.53. It has increased from 70.42 (Mar 24) to 75.53, marking an increase of 5.11.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 57.33. It has increased from 57.26 (Mar 24) to 57.33, marking an increase of 0.07.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 13.29. This value is within the healthy range. It has increased from 11.96 (Mar 24) to 13.29, marking an increase of 1.33.
• For PBIT / Share (Rs.), as of Mar 25, the value is 9.90. This value is within the healthy range. It has increased from 8.84 (Mar 24) to 9.90, marking an increase of 1.06.
• For PBT / Share (Rs.), as of Mar 25, the value is 8.33. This value is within the healthy range. It has increased from 6.99 (Mar 24) to 8.33, marking an increase of 1.34.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 5.88. This value is within the healthy range. It has increased from 4.87 (Mar 24) to 5.88, marking an increase of 1.01.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 5.92. This value is within the healthy range. It has increased from 4.90 (Mar 24) to 5.92, marking an increase of 1.02.
• For PBDIT Margin (%), as of Mar 25, the value is 23.17. This value is within the healthy range. It has increased from 20.89 (Mar 24) to 23.17, marking an increase of 2.28.
• For PBIT Margin (%), as of Mar 25, the value is 17.26. This value is within the healthy range. It has increased from 15.43 (Mar 24) to 17.26, marking an increase of 1.83.
• For PBT Margin (%), as of Mar 25, the value is 14.52. This value is within the healthy range. It has increased from 12.20 (Mar 24) to 14.52, marking an increase of 2.32.
• For Net Profit Margin (%), as of Mar 25, the value is 10.24. This value exceeds the healthy maximum of 10. It has increased from 8.50 (Mar 24) to 10.24, marking an increase of 1.74.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 10.31. This value is within the healthy range. It has increased from 8.55 (Mar 24) to 10.31, marking an increase of 1.76.
• For Return on Networth / Equity (%), as of Mar 25, the value is 7.83. This value is below the healthy minimum of 15. It has increased from 6.95 (Mar 24) to 7.83, marking an increase of 0.88.
• For Return on Capital Employeed (%), as of Mar 25, the value is 8.32. This value is below the healthy minimum of 10. It has increased from 7.77 (Mar 24) to 8.32, marking an increase of 0.55.
• For Return On Assets (%), as of Mar 25, the value is 3.80. This value is below the healthy minimum of 5. It has increased from 3.15 (Mar 24) to 3.80, marking an increase of 0.65.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has decreased from 0.04 (Mar 24) to 0.02, marking a decrease of 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.16. This value is within the healthy range. It has decreased from 0.24 (Mar 24) to 0.16, marking a decrease of 0.08.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.36. It has decreased from 0.37 (Mar 24) to 0.36, marking a decrease of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 2.61. This value is within the healthy range. It has increased from 2.28 (Mar 24) to 2.61, marking an increase of 0.33.
• For Quick Ratio (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has increased from 0.59 (Mar 24) to 0.73, marking an increase of 0.14.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.32. This value is below the healthy minimum of 4. It has decreased from 0.41 (Mar 24) to 0.32, marking a decrease of 0.09.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 62.86 (Mar 24) to 0.00, marking a decrease of 62.86.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 38.38 (Mar 24) to 0.00, marking a decrease of 38.38.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 37.14 (Mar 24) to 0.00, marking a decrease of 37.14.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 61.62 (Mar 24) to 0.00, marking a decrease of 61.62.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 8.45. This value is within the healthy range. It has increased from 6.48 (Mar 24) to 8.45, marking an increase of 1.97.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.74. This value is within the healthy range. It has increased from 3.64 (Mar 24) to 4.74, marking an increase of 1.10.
• For Enterprise Value (Cr.), as of Mar 25, the value is 5,288.07. It has decreased from 7,684.98 (Mar 24) to 5,288.07, marking a decrease of 2,396.91.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.92. This value exceeds the healthy maximum of 3. It has decreased from 7.16 (Mar 24) to 4.92, marking a decrease of 2.24.
• For EV / EBITDA (X), as of Mar 25, the value is 21.24. This value exceeds the healthy maximum of 15. It has decreased from 34.29 (Mar 24) to 21.24, marking a decrease of 13.05.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.75. This value exceeds the healthy maximum of 3. It has decreased from 6.88 (Mar 24) to 4.75, marking a decrease of 2.13.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 37.13 (Mar 24) to 0.00, marking a decrease of 37.13.
• For Price / BV (X), as of Mar 25, the value is 3.61. This value exceeds the healthy maximum of 3. It has decreased from 5.59 (Mar 24) to 3.61, marking a decrease of 1.98.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.75. This value exceeds the healthy maximum of 3. It has decreased from 6.88 (Mar 24) to 4.75, marking a decrease of 2.13.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness